Low Evidence
Research Overview
MK-677 Research for Bone Density
An evidence-based overview of research examining MK-677 in the context of bone density. This page synthesizes findings from peer-reviewed literature.
Research Summary
An eight-week study of 24 obese men and a pooled elderly-adult report measured bone-turnover markers. In 292 postmenopausal women, adding MK-677 to alendronate improved femoral-neck bone mineral density versus alendronate alone, but not lumbar-spine, total-hip, or total-body density. Marker and site-specific changes do not establish fracture prevention.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Always consult a healthcare provider before making health decisions.